COMPDRUG INC
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$12,309,405
Program Services
77%
Government Grants
22%
Investments
<1%
Contributions
<1%
Fundraising Events
0%
Membership Dues
0%
Other
0%
Expenses in 2024
$12,514,718
Salaries & Benefits
64%
Other
21%
Fees to Service Providers
7%
Offices, Occupancy & IT
6%
Depreciation
2%
Advertising & Promotion
<1%
Interest
<1%
Grants
0%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$21,956
$9,867
-55%
Government Grants
$2,960,132
$2,761,138
-7%
Fundraising Events
$0
$0
-
Program Services
$9,539,052
$9,466,915
-1%
Membership Dues
$0
$0
-
Investments
$51,355
$71,485
+39%
Other
$8,500
$0
-100%
Total Revenues
$12,580,995
$12,309,405
-2%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$7,859,238
$8,029,012
+2%
Fees to Service Providers
$1,096,431
$855,165
-22%
Advertising & Promotion
$118,311
$52,004
-56%
Offices, Occupancy & IT
$1,115,483
$716,513
-36%
Interest
$46,442
$9,794
-79%
Depreciation
$240,590
$266,124
+11%
Other
$2,266,287
$2,586,106
+14%
Total Expenses
$12,742,782
$12,514,718
-2%
Net income
2023
2024
Change
Net income
-$161,787
-$205,313
-27%
Functional Expenses
Summary
2023
2024
Change
Program
$9,552,530
$9,446,239
-1%
Admin
$2,911,509
$2,879,037
-1%
Fundraising
$278,743
$189,442
-32%
Total Expenses
$12,742,782
$12,514,718
-2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)